Abstract
Flow Cytometry-Based Detection of Minimal/Measurable Residual Disease Predicts Survival Outcomes in Pediatrics, Adolescents, and Young Adults With T-acute Lymphoblastic Leukemia
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have